在Seremban的糖尿病患者中,他类药物的使用与抑郁症之间的关系:一个横截面研究
S V Pannir1, Z F Zakaria2, K V Surendren3
1IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.
The Medical journal of Malaysia
|March 27, 2025
概括
这项研究发现,在2型糖尿病患者中,他类药物使用和抑郁症之间没有显著的联系. 压力,焦虑和对药物的信仰与抑郁症有关,而不是他类药物的强度.
科学领域:
- 医学研究 医学研究
- 临床药房 临床药房
- 精神病学是一个精神病学.
背景情况:
- 类药物在初级保健中被广泛使用.
- 超脂血症和糖尿病与抑郁症有关.
- 抑郁症与较差的糖尿病和超脂血症控制有关.
研究的目的:
- 确定在2型糖尿病患者中使用他类药物和抑郁症之间的关联.
- 调查他类药物剂量强度与抑郁症患病率之间的关系.
- 在这个患者群体中确定与抑郁症相关的因素.
主要方法:
- 在Seremban健康诊所进行了回顾性横截面研究.
- 通过面试者指导的问卷 (DASS-21,BMQ,MyMAAT,PHQ-9) 收集的数据.
- 82名成年2型糖尿病患者被录取.
主要成果:
- 25%的患者经历了抑郁症.
- 增加他类药物剂量强度显示出非显著的趋势,抑郁症患病率更高.
- 压力,焦虑,对药物的信仰和婚姻状况与抑郁症有显著的关联;在调整后,只有压力仍然很重要.
结论:
- 在2型糖尿病患者中,使用他类药物和抑郁症之间没有发现统计学上显著的关联.
- 需要进一步的研究来阐明这种人群中抑郁症的原因.
- 压力是与2型糖尿病患者抑郁症相关的重要因素.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
155
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14.5K
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
484
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
484
Antidepressant Drugs: MAOIs and Other Agents
173
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
173
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
257
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
257
Antidepressant Drugs: Overview
341
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
341
Psychoneuroimmunology: Diabetes and Cancer
20
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
20
Dipeptidyl Peptidase 4 Inhibitors
146
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
146
